The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1572
ISSUE1572
May 20, 2019
PrabotulinumtoxinA (Jeuveau) for Frown Lines
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
PrabotulinumtoxinA (Jeuveau) for Frown Lines
May 20, 2019 (Issue: 1572)
The FDA has approved prabotulinumtoxinA-xvfs
(Jeuveau – Evolus) for temporary improvement in
the appearance of moderate to severe glabellar lines
associated with corrugator and/or procerus muscle
activity. Jeuveau is the fourth botulinum...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.